|
|
|
|
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-MMP17 antibody - Aminoterminal end(ab39028)

(enlarge)
|
|
Immunocytochemistry/ Immunofluorescence - MMP17 antibody - Aminoterminal end (ab39028)

(enlarge)
|
|
|
|
|
Product Name
|
MMP17 antibody - Aminoterminal end
|
| |
See all MMP17 antibodies (6)...
|
|
Product type
|
Primary antibodies
|
|
Description
|
Rabbit polyclonal to MMP17 - Aminoterminal end
|
|
Immunogen
|
Synthetic peptide from Human MMP17 corresponding to the aminoterminal end.
(Peptide available as ab41102.)
|
|
Reacts with
(species key)
|
Hu
|
|
Specificity
|
This antibody binds to the aminoterminal end of active MMP17. It can recognize native or reduced MMP17, but does not cross react with the other MMP family members (MMP1, MMP2, MMP3, MMP9,etc.).
We have a range of domain specific antibodies for this target. For a full list please see all MMP17 antibodies
|
|
Tested applications
(see key)
|
ICC/IF, IHC-P, WB
|
|
|
Abreviews
|
|
|
|
Application notes
(see key)
|
Recommended dilutions ICC/IF: Use at a concentration of 1 µg/ml. IHC-P: Use at a concentration of 4 µg/ml. Perform heat mediated antigen retrieval with EDTA buffer pH 9.0 before commencing with IHC staining protocol.
WB: 1/1000 when using colorimetric substrates such as BCIP/NBT - 1/5000 when using chemiluminescent substrates. Predicted molecular weight: 67 kDa. When used against the reduced protein, ab39028 identifies bands at 65 kD and 63 kD (the pro-form and active form), as well as activation/breakdown products. Note: Treatment of cells with Concanavolin-A or the phorbol ester TPA stimulates production of MMP17 in some cell types, and the enzyme can be recovered in cell lysates. Dilution optimised using Chromogenic detection.
Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
|
|
Cellular localization
|
Cell membrane; lipid anchor; GPI anchor; extracellular side.
|
|
Research areas
|
Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Metalloprotease >> MMPs Cancer >> Invasion/microenvironment >> ECM >> Extracellular matrix >> MMPs Cancer >> Invasion/microenvironment >> Angiogenesis >> ECM enzymes >> MMPs Signal Transduction >> Cytoskeleton / ECM >> Extracellular Matrix >> ECM Enzymes >> MMP Cardiovascular >> Angiogenesis >> Adhesion / ECM >> Matrix Metalloproteinases >> MMP
|
|
Relevance
|
The matrix metalloproteinases (MMPs) are a family of at least eighteen secreted and membrane bound zincendopeptidases. Collectively, these enzymes can degrade all the components of the extracellular matrix, including fibrillar and non fibrillar collagens, fibronectin, laminin and basement membrane glycoproteins. In general, a signal peptide, a propeptide, and a catalytic domain containing the highly conserved zinc binding site characterizes the structure of the MMPs. In addition, fibronectin like repeats, a hinge region, and a C terminal hemopexin like domain allow categorization of MMPs into the collagenase, gelatinase, stomelysin and membrane type MMP subfamilies. All MMPs are synthesized as proenzymes, and most of them are secreted from the cells as proenzymes. Thus, the activation of these proenzymes is a critical step that leads to extracellular matrix breakdown. MMPs are considered to play an important role in wound healing, apoptosis, bone elongation, embryo development, uterine involution, angiogenesis and tissue remodeling, and in diseases such as multiple sclerosis, Alzheimer's, malignant gliomas, lupus, arthritis, periodontis, glumerulonephritis, atherosclerosis, tissue ulceration, and in cancer cell invasion and metastasis.
MMP17 has been reported to be elevated in several tumor cell lines, and is constituitively produced by some normal cell lines. Treatment of cells with Concanavolin A or the phorbol ester TPA stimulates production of MMP17 in some cell types, and the enzyme can be recovered in cell lysates. Shed forms of MMP17 have also been reported.
|
|
|
|
|
Database links
|
The links below go to external sites and will open in a new browser window
|
|
Raised in
|
Rabbit
|
|
Clonality
|
Polyclonal
|
|
Isotype
|
IgG
|
|
Purity
|
Immunogen affinity purified
|
|
Storage buffer
|
Preservative: 0.05% Sodium Azide Constituents: 50% Glycerol Material safety datasheets (MSDS) for this product: Glycerol MSDS Sodium Azide MSDS
|
|
Form
|
Liquid
|
|
Concentration
|
1.000 mg/ml
|
|
Storage instructions
|
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.
|
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this MMP17 antibody - Aminoterminal end is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
|
See below for MMP17 antibody - Aminoterminal end images, references, products related to ab39028 and other tools.
|
| |
MMP17 antibody - Aminoterminal end images:
|
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-MMP17 antibody - Aminoterminal end(ab39028)
Ab39028 staining human normal ovary. Staining is localised to plasma membrane. Left panel: with primary antibody at 4 ug/ml. Right panel: isotype control. Sections were stained using an automated system DAKO Autostainer Plus , at room temperature. Sections were rehydrated and antigen retrieved with the Dako 3-in-1 antigen retrieval buffer EDTA pH 9.0 in a DAKO PT Link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 minutes. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 minutes and detected with Dako Envision Flex amplification kit for 30 minutes. Colorimetric detection was completed with diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.
|
| |
Immunocytochemistry/ Immunofluorescence - MMP17 antibody - Aminoterminal end (ab39028)
ICC/IF image of ab39028 stained Hek293 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab39028, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
|
| |
| |
|
Search PubMed (MEDLINE) for references to MMP17
|
| |
MMP17 antibody - Aminoterminal end - more information
|
Customer reviews (feedback) regarding MMP17 antibody - Aminoterminal end |
Customer FAQs regarding MMP17 antibody - Aminoterminal end |
Protocols for MMP17 antibody - Aminoterminal end |
Price and availability of products related to MMP17 antibody - Aminoterminal end |
| |
MMP17 antibody - Aminoterminal end - related products:
|
|
|
| |
MMP17 antibody - Aminoterminal end - other tools:
|
Contact Abcam with a Technical Enquiry about MMP17 antibody - Aminoterminal end |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"